Quick Answer
GLP-1 is the broader drug class. Ozempic is one specific brand-name medication within that class: an injectable semaglutide product approved by the FDA for adults with type 2 diabetes, not specifically for weight loss. In practice, when people say “GLP-1,” they often mean the whole category of drugs used for diabetes or obesity, while Ozempic is just one member of that group.
Comparison Table
| Term or Drug | What it actually means | FDA-approved use | What shoppers usually get wrong |
|---|---|---|---|
| GLP-1 | A class of medications that mimic the GLP-1 hormone | Depends on the specific drug | People use it like it’s one drug, but it’s a whole category |
| Ozempic | Brand-name semaglutide injection | Type 2 diabetes in adults; also used to reduce major cardiovascular risk in certain adults with type 2 diabetes | People often think Ozempic is the official weight-loss version, but it is not |
| Wegovy | Brand-name semaglutide injection at obesity-specific dosing | Chronic weight management; also approved to reduce cardiovascular risk in certain adults with CVD and obesity/overweight | People assume Wegovy and Ozempic are identical products used interchangeably for the same labeled purpose |
| Zepbound | Brand-name tirzepatide, a dual GIP/GLP-1 drug | Chronic weight management; also approved for obstructive sleep apnea in adults with obesity | People lump it in casually as “a GLP-1” even though it is technically a dual agonist |
GLP-1 is the category. Ozempic is the brand.
The simplest way to understand this: GLP-1 is the umbrella, Ozempic is one product under it.
GLP-1 stands for glucagon-like peptide-1. Drugs in this category mimic or act on that hormone pathway to help regulate blood sugar, slow gastric emptying, and reduce appetite. That means Ozempic is not “different from GLP-1” in the way people often ask — it is a GLP-1 drug.
This is why the question gets confusing online. Someone asks, “Should I take GLP-1 or Ozempic?” But that is a little like asking, “Should I buy skincare or this one serum?” One is the category. The other is a specific item inside the category.
Ozempic is semaglutide, but it is not the only semaglutide brand
Ozempic is a brand name for injectable semaglutide. The FDA says semaglutide is also sold as Rybelsus tablets for type 2 diabetes and Wegovy injection for chronic weight management. So if you hear semaglutide discussed in weight-loss conversations, that does not automatically mean Ozempic — it may actually mean Wegovy.
This matters because a lot of people use “Ozempic” as shorthand for all modern weight-loss injections. In real medical and regulatory terms, Ozempic is specifically the diabetes brand, while Wegovy is the obesity brand, even though both involve semaglutide.
The real difference is usually indication, dose, and insurance pathway
For most consumers, the biggest practical difference is not chemistry. It is what the drug is officially approved for, how it is dosed, and whether insurance is likely to cover it.
Ozempic is FDA-approved for adults with type 2 diabetes. Wegovy is FDA-approved for chronic weight management in adults with obesity, or overweight plus at least one weight-related condition. Wegovy also has a cardiovascular risk-reduction indication in certain adults with cardiovascular disease and obesity or overweight.
That means if your goal is weight loss and you do not have type 2 diabetes, the more technically aligned branded semaglutide product is usually Wegovy, not Ozempic. But people still chase Ozempic because it became the most culturally famous name first.
Not every “GLP-1” is Ozempic
There are multiple drugs in this space. When people say “I want a GLP-1,” they might mean semaglutide, but they may also mean liraglutide, or increasingly tirzepatide, which is often grouped into the same market conversation even though it is technically a dual GIP/GLP-1 agonist.
That means “GLP-1” could refer to Ozempic, Wegovy, Rybelsus, Saxenda, a newer obesity medication in the same broader conversation, or even a telehealth-marketed compounded product that is not FDA-approved. So if you are comparing options, do not stop at the class name. You need to know the exact product.
Why this distinction matters more in 2026
The distinction between “GLP-1” and “Ozempic” matters even more now because the market is more crowded and more regulated.
First, semaglutide shortage conditions have changed. The FDA said on February 21, 2025 that the shortage of semaglutide injection products was resolved, though localized supply disruptions could still occur. That matters because a lot of the telehealth compounding boom was justified publicly around shortages.
Second, in February and March 2026, the FDA announced tougher action against non-FDA-approved compounded GLP-1 drugs and sent warning letters to telehealth companies over misleading compounded-GLP-1 marketing claims. The agency emphasized that compounded drugs are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing.
So if someone says they are “on a GLP-1,” that now tells you less than it used to. Are they on Ozempic? Wegovy? Zepbound? A compounded product? In 2026, that distinction is not cosmetic — it is central.
What readers should ask instead
Instead of asking “GLP-1 vs Ozempic,” the better questions are:
- Do I mean the drug class or a specific brand?
- Am I being prescribed this for type 2 diabetes or weight loss?
- Is the product FDA-approved for my use case?
- Am I getting Ozempic, Wegovy, another brand, or a compounded version?
- What is the real monthly cost and insurance pathway for the exact product?
Verdict
If you are choosing between “GLP-1” and “Ozempic,” you are asking the wrong question. Ozempic is a GLP-1 drug. The smarter question is which specific medication fits your actual goal: diabetes management, weight loss, cardiovascular risk reduction, or something else. For weight loss, focus less on the celebrity aura of Ozempic and more on whether the exact product you’re considering is the right FDA-approved option for your situation.
Ready to explore your options?
If you are considering a GLP-1 medication, here are a few telehealth providers currently offering prescriptions. Each link goes to the provider’s site where you can learn more about eligibility, pricing, and next steps:
- Care Bare Rx — GLP-1 prescriptions with clinical support
- TMates — prescription weight loss programs
- Direct Meds — GLP-1 medication access
Disclosure: RangeYourself may earn a commission if you sign up through the links above. This does not affect our editorial recommendations.
FAQ
Is Ozempic the same thing as GLP-1?
No. GLP-1 is the drug class; Ozempic is one specific semaglutide brand within that class.
Which is better for weight loss, GLP-1 or Ozempic?
That comparison is not quite logical because Ozempic is itself a GLP-1 drug. The real comparison is usually Ozempic versus Wegovy, Zepbound, or another specific medication.
Is Ozempic officially approved for weight loss?
Ozempic is FDA-approved for type 2 diabetes in adults. Wegovy is the semaglutide brand FDA-approved for chronic weight management.
Why do people call all weight-loss shots “Ozempic”?
Because Ozempic became the most culturally recognizable name early on. But medically and commercially, many people actually mean Wegovy, Zepbound, or another product.
Are compounded GLP-1 drugs the same as Ozempic?
No. The FDA says compounded drugs are not FDA-approved and should not be marketed as if they are the same as approved branded products.
Has the semaglutide shortage ended?
The FDA said in February 2025 that the shortage of semaglutide injection products was resolved, though local supply disruptions can still happen.